Axumin

Axumin (Fluciclovine (18F)) is a radiopharmaceutical used for diagnostic imaging. It is designed to help identify areas of increased amino acid metabolism, commonly used in PET scans.

Axumin is primarily used in positron emission tomography (PET) scans to detect recurrent prostate cancer. It helps in identifying areas with high amino acid metabolism, which can indicate the presence of cancerous cells. This diagnostic tool is often used when other imaging methods are inconclusive.

Axumin is administered intravenously and works by being absorbed by cells with high metabolic activity. The radioactive tracer allows for clear imaging of these areas, aiding in the diagnosis and monitoring of certain types of cancer.

Axumin should be handled with care due to its radioactive nature. It is important to follow all safety protocols when administering this medication. Patients should inform their healthcare provider about any allergies or medical conditions before undergoing a PET scan with Axumin.

There are no known significant drug interactions with Axumin. However, it is always advisable to inform your healthcare provider about all medications you are taking before undergoing any diagnostic procedure.